Mainz Biomed

接昨天的帖子， ARBK 的操作是明确的失败了，无论是选股还是时机都存在问题，目前浮亏中。
昨日（12月2日）操作：
交易不能停止，昨天在反思 ARBK 的同时，新开仓了 MYNZ (Mainz Biomed)。
公司简介与交易逻辑：
MYNZ 是一家分子遗传学诊断公司，核心资产是其非侵入性结直肠癌（CR...

$Mainz Biomed(MYNZ)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0002105585-26-000002  Size: 3 KB 网页链接

$Mainz Biomed(MYNZ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002105585-26-000003  Size: 4 KB 网页链接

$Mainz Biomed(MYNZ)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-007696  Size: 6 KB 网页链接

$Mainz Biomed(MYNZ)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-007704  Size: 6 KB 网页链接

$Mainz Biomed(MYNZ)$ 美国公民Kevin Michael Donahue已为MAINZ BIOMED N.V.普通股提交了Schedule 13G文件。截至2026年1月16日，Donahue实益拥有643,850股，占该类别股份的10.7%。这构成了所有权变更，先前持股为0.0股。文件显示Donahue对这些股份拥有唯一的投票权和处置权。Donahue的主要业务办公...

$Mainz Biomed(MYNZ)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-25-115593  Act: 33  Size: 736 KB 网页链接

$Mainz Biomed(MYNZ)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-007695  Size: 7 KB 网页链接

$Mainz Biomed(MYNZ)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-25-115584  Act: 34  Size: 209 KB 网页链接

$Mainz Biomed(MYNZ)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-25-126132  Act: 33  Size: 1 MB 网页链接

$Mainz Biomed(MYNZ)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0002105585-26-000005  Size: 4 KB 网页链接

$Mainz Biomed(MYNZ)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002105585-26-000006  Act: 34  Size: 5 KB 网页链接

$Mainz Biomed(MYNZ)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-25-118787  Act: 33  Size: 1 MB 网页链接

$Mainz Biomed(MYNZ)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003935  Act: 33  Size: 1 KB 网页链接

$Mainz Biomed(MYNZ)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-25-126130  Act: 33  Size: 17 KB 网页链接

$Mainz Biomed(MYNZ)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0002105585-26-000004  Size: 3 KB 网页链接

$Mainz Biomed(MYNZ)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002105585-26-000001  Act: 34  Size: 5 KB 网页链接

$Mainz Biomed(MYNZ)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-26-007708  Size: 9 KB 网页链接